MAY 26, 2016 12:43 PM PDT

Suppressing Peant Allergy Anaphylaxis with Histamine Blockers

WRITTEN BY: Kara Marker
All antihistamine drugs on the market today block only the H1 receptor, but there are three more histamine receptors that are involved in the allergic immune response that are present on the surface of several body cell types. New research shows that simultaneously blocking two different histamine receptors can inhibit gastrointestinal symptoms to the point where people with peanut allergies might be able to safely consume peanut products.
 

Recent studies have shown that exposure early in life to peanuts can help prevent the development of peanut allergies as people mature. However, for people who already have an allergy, the only existing, effective measure to prevent life-threatening symptoms is to avoid contact with the allergen. A new study from National Jewish Health might be the answer for people with both peanut allergies and peanut cravings.

The study, which was recently published in the journal Allergy, involved mice models of peanut allergy that were already sensitized to peanuts. The researchers first treated the mice with oral doses of H1 receptor blockers and H4 receptor blockers separately, done during the “challenge phase” as the mice encountered peanuts. 

The response was essentially the same for mice receiving either individual dose of either H1 or H4 receptor blockers: “partial suppression, plus decreased numbers of dendritic cells in mesenteric lymph nodes and lamina propria.”

On the other hand, when researchers gave oral doses of a combination of H1 and H4 receptor blockers during the challenge phase, gastrointestinal symptoms like diarrhea, intestinal inflammation, and others were prevented almost entirely. 

Histamine is a chemical released by immune cells like basophils and mast cells in times of allegy as well as in times of stress. Histamine can trigger a variety of responses associated with an allergy, such as inflammation, itchiness, and mucus production. These responses occur because of  histamine’s effect on the body: dilating blood vessels, bronchoconstriction. In addition to playing a primary role in food allergies, histamine is also a key player in conditions like asthma and hay fever. 

Throughout the study, researchers measured a variety of interactions to understand the full story of how blocking histamine receptors inhibits the allergic response: dendritic cell chemotaxis, calcium mobilization, and antigen-presenting cell function. The H1 receptor antagonist they used, loratadine, is a drug present in common allergy alleviator Claritin. The H4 receptor antagonist is an experimental drug, called JNJ7777120. 

The also completed several in vitro experiments to visualize at the cellular level how the antihistamine drugs suppressed the allergic response. They saw the histamine receptor blockers work by inhibiting accumulation and function of dendritic cells, antigen-presenting cells of the immune system that normally present peanut proteins to T lymphocytes in people with peanut allergies.
As many as 15 million Americans are believed to have some sort of food allergies, and many are at risk for life-threatened anaphylaxis. This exciting new research shows much promise for treating the most severe allergies and improving the quality of life for millions of people with allergies.
 

Sources: National Jewish Health, Allergy & Immunology Associates of Michigan, Food Allergy & Research Education
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 01, 2021
Coronavirus
It Seems Not All COVID-19 Patients Develop Antibodies
SEP 01, 2021
It Seems Not All COVID-19 Patients Develop Antibodies
It's been generally assumed that people who get infected with SARS-COV-2 will develop antibodies to the virus, which cau ...
SEP 09, 2021
Cancer
Can a Mole Fight Melanoma?
SEP 09, 2021
Can a Mole Fight Melanoma?
About 30% of melanoma cases arise from an existing nevus.  More commonly known as moles, Nevi are skin growths that ...
SEP 07, 2021
Earth & The Environment
The Future of Flooding
SEP 07, 2021
The Future of Flooding
In the wake of recent flooding on the east coast as a result of Hurricane Ida, many people are wondering what the future ...
SEP 13, 2021
Cancer
Fat Loss can Predict Gastric Cancer Survival
SEP 13, 2021
Fat Loss can Predict Gastric Cancer Survival
Cancer cachexia is a metabolic disorder in cancer patients experiencing uncontrolled weight loss.  While cancer cac ...
SEP 24, 2021
Cell & Molecular Biology
A Human Embryo Model is Made From Stem Cells
SEP 24, 2021
A Human Embryo Model is Made From Stem Cells
This photo by Sozen & Jorgensen et al., Nature Communications, shows an embryo-like structure made from human stem cells ...
SEP 26, 2021
Technology
How Light Therapy Could Help People With Alzheimer's Disease
SEP 26, 2021
How Light Therapy Could Help People With Alzheimer's Disease
Light therapy can refer to many things, though it generally describes the use of some kind of light source--whether natu ...
Loading Comments...